Announced Mon, 29 Jun · 15:59 IST
Trading Window Closed for Q1 FY27 Results
Compliance View source PDF
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹955.00
prior close
₹960.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.3-0.1-0.6+2.4+1.8+1.5+3.0+2.8+1.9+5.2———
Up moveDown movePending
AI summary
Jubilant Pharmova has closed its trading window from July 1, 2026 until 48 hours after announcing Q1 FY27 (quarter ending June 30, 2026) unaudited standalone and consolidated financial results. This is a routine SEBI insider trading compliance measure. Designated persons and their immediate relatives cannot trade in company shares during this period. The board meeting date for Q1 results will be announced later.
Likely market impact
Routine compliance filing. Signals upcoming Q1 FY27 earnings announcement. No direct impact on retail shareholders.